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Abstract
Background: Sepsis is a major healthcare problem and current estimates suggest that the incidence of sepsis is
approximately 750,000 annually. Sepsis is caused by an inability of the immune system to eliminate invading pathogens. It
was recently proposed that endogenous mediators produced during sepsis can contribute to the immune dysfunction that
is observed in sepsis. Endocannabinoids that are produced excessively in sepsis are potential factors leading to immune
dysfunction, because they suppress immune cell function by binding to G-protein-coupled CB2 receptors on immune cells.
Here we examined the role of CB2 receptors in regulating the host’s response to sepsis.
Methods and Findings: The role of CB2 receptors was studied by subjecting CB2 receptor wild-type and knockout mice to
bacterial sepsis induced by cecal ligation and puncture. We report that CB2 receptor inactivation by knockout decreases
sepsis-induced mortality, and bacterial translocation into the bloodstream of septic animals. Furthermore, CB2 receptor
inactivation decreases kidney and muscle injury, suppresses splenic nuclear factor (NF)-kB activation, and diminishes the
production of IL-10, IL-6 and MIP-2. Finally, CB2 receptor deficiency prevents apoptosis in lymphoid organs and augments
the number of CD11b
+ and CD19
+ cells during CLP.
Conclusions: Taken together, our results establish for the first time that CB2 receptors are important contributors to septic
immune dysfunction and mortality, indicating that CB2 receptors may be therapeutically targeted for the benefit of patients
suffering from sepsis.
Citation: Cso ´ka B, Ne ´meth ZH, Mukhopadhyay P, Spolarics Z, Rajesh M, et al. (2009) CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in
Polymicrobial Sepsis. PLoS ONE 4(7): e6409. doi:10.1371/journal.pone.0006409
Editor: Neeraj Vij, Johns Hopkins School of Medicine, United States of America
Received June 2, 2009; Accepted June 22, 2009; Published July 29, 2009
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was supported by the National Institutes of Health (NIH) Grant GM066189-05A2 and the Intramural Research Program of NIH, National
Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pacher@mail.nih.gov (PP); haskoge@umdnj.edu (GH)
Introduction
Sepsis is defined as systemic illness caused by microbial invasion
of normally sterile parts of the body. Sepsis is a major healthcare
problem because its incidence is in the order of sepsis is in the
order of 750,000 annually, and sepsis causes more than 200,000
deaths each year in the United States alone [1,2]. Currently,
therapeutic management of sepsis is limited mostly to supportive
measures, in a large part due to a failure to fully establish the
pathophysiology of this complex and heterogeneous syndrome.
Multiple organ dysfunction syndrome and death in sepsis are
consequences of an inability to kill invading pathogens effectively
due to immunosuppression [3,4]. Potentially contributing to
immune suppression after a septic insult are immune cell
apoptosis, inefficient phagocytosis of microbial pathogens by
neutrophils and macrophages, decreased ability of antigen-
presenting cells to present antigens, as well as decreased
responsiveness of macrophages and T cells to release proinflam-
matory cytokines in conjunction with overzealous production of
the anti-inflammatory cytokine IL-10 [5–7].
One view holds that immune dysfunction during sepsis is a
result of autocrine/paracrine immunoregulatory mediators that
are produced primarily at the site of infection/injury (including the
bloodstream) and suppress immune cell function via acting on G-
protein-coupled receptors. One group of these mediators are
endocannabinoids, which elicit their cellular effects by binding to
two subtypes of G-protein-coupled cannabinoid receptor proteins
on the cell surface, termed CB1 and CB2 receptors [8–10].
Endocannabinoids are released from macrophages, dendritic cells,
platelets, and parenchimal cells in response to inflammatory
stimuli and oxidative stress [11–15] and are present at elevated
concentrations in the sera of patients and animals suffering from
septic, hemorrhagic or cardiogenic shock [16–20]. CB2 receptors
are the dominant cannabinoid receptors on macrophages,
neutrophils, and lymphocytes, and triggering CB2 receptors has
an overall anti-inflammatory and immunosuppressive effect [21].
CB2 receptor activation augments the production of the anti-
inflammatory cytokine, IL-10, by murine macrophages [22], and
disrupts antigen processing by these cells, which leads to
incomplete antigen-presentation to T cells [23,24].
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CB2 receptors regulate immune function, the role of CB2 receptors
in regulating bacterial sepsis is unknown. In the present study,
using a genetic approach we examined the role of CB2 receptors in
regulating the host’s response to polymicrobial sepsis.
Materials and Methods
Experimental animals
CB2 knockout (KO) mice and their wild-type (WT) littermates
were developed as described previously and had been backcrossed
to a C57Bl/6J background [14]. All mice were maintained in
accordance with the recommendations of the ‘‘Guide for the Care
and Use of Laboratory Animals’’, and the experiments were
approved by the New Jersey Medical School Animal Care
Committee.
Cecal ligation and puncture (CLP)
Polymicrobial sepsis was induced by subjecting mice to CLP, as
we have described previously [25,26]. Eight- to twelve-week-old
male CB2 KO or WT mice were anesthetized with Pentobarbital
(50 mg/kg), given intraperitoneally (i.p.). Under aseptic condi-
tions, a 2-cm midline laparotomy was performed to allow exposure
of the cecum with adjoining intestine. Approximately two-thirds of
the cecum was tightly ligated with a 3.0 silk suture, and the ligated
part of the cecum was perforated twice (through and through) with
a 20-gauge needle (BD Biosciences). The cecum was then gently
squeezed to extrude a small amount of feces from the perforation
sites. The cecum was then returned to the peritoneal cavity and
the laparotomy was closed in two layers with 4.0 silk sutures. The
mice were resuscitated with 1 ml of physiological saline injected
subcutaneously (s.c.) and returned to their cages with free access to
food and water. One group of mice was monitored daily and
survival was recorded for 7 days. Another group of mice was
reanesthetized with Pentobarbital (80 mg/kg i.p.) 16 hour after
the operation, and blood, peritoneal lavage fluid, and various
organs were harvested.
Collection of blood, peritoneal lavage fluid, and organs
Blood samples were obtained aseptically by cardiac puncture
using heparinized syringes after opening the chest and placed on
ice into heparinized Eppendorf tubes until further processing for
bacteriological analysis. After serial dilutions for bacteriological
analysis were made (see below), the blood was centrifuged at
2,0006g for 10 min and the recovered plasma was stored at
270uC until further use. For peritoneal lavage, the abdominal skin
was cleansed with 70% ethanol and the abdominal wall was
exposed by opening the skin. Two milliliters of sterile physiological
saline were then installed into the peritoneal cavity via an 18-
gauge needle. The abdomen was massaged gently for 1 min while
keeping the tip of the needle in the peritoneum, after which
peritoneal fluid was recovered through the needle. Recovered
peritoneal lavage fluid was placed on ice until processed for
bacteriological examination. After serially diluting the peritoneal
lavage fluid to determine colony forming unit (CFU) numbers (see
below), the peritoneal lavage fluid was centrifuged at 5,0006g for
10 min and the supernatant was stored at 270uC until further
analysis. Samples from spleen and thymus, were excised and
immediately frozen in liquid nitrogen.
Quantification of bacterial CFUs from peritoneal lavage
fluid and blood
100 ml of blood or peritoneal lavage fluid was diluted serially in
sterile physiological saline. 50 ml of each dilution was aseptically
plated and cultured on trypticase blood agar plates (BD
Biosciences) at 37uC. After 24 hours, the number of bacterial
colonies was counted. Quantitative cultures are expressed as CFUs
per milliliter of blood or peritoneal lavage fluid.
Flow cytometric analysis of leukocyte subsets
Flow cytometric detection of leukocyte subsets was performed as
previously described [27]. In brief, the percent distribution of
leukocyte subsets in blood was analyzed by specifically staining
CD3
+ T-cells, CD19
+ B-cells and CD11b
+ myeloid cells using
antibodies against CD markers conjugated with FITC, PERCP or
PE (BD Biosciences) in three-color incubations. Aliquots of 0.1 ml
whole blood were incubated with the respective markers for
15 min followed by incubation with BD FACS lysing solution (BD
Biosciences) for 7 min at 37uC. Cells were washed twice with BD
FACS wash buffer and then fixed with 1% methanol free
formaldehyde. FACS acquisitions were performed in a centralized
flow cytometry facility. At least 30,000 events were collected for
each analysis.
Protein extraction and Western blot analysis
Frozen organs were homogenized in a Dounce homogenizer in
modified radioimmunoprecipitation assay buffer (50 mM Tris
HCl, 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycho-
late, 1% Nonidet P-40, 1 mg/ml pepstatin, 1 mg/ml leupeptin,
1m MP M S F ,1m MN a 3VO4). The lysates were centrifuged at
15,0006g for 15 min, and the supernatant was recovered.
Protein concentrations were determined using the Bio-Rad
protein assay kit. A total of 40 mg of sample was separated on
8–12% Tris-glycine gel (Invitrogen Life Technologies) and
transferred to nitrocellulose membrane. The membranes were
probed with polyclonal rabbit anti-cleaved caspase-3, polyclonal
rabbit anti-cleaved poly(ADP-ribose) polymerase (PARP), and
polyclonal rabbit anti- inhibitory subunit of nuclear factor (NF)-
kB( I kBa), (all from Cell Signaling Technology). Thereafter, the
membranes were incubated with a secondary HRP-conjugated
anti-rabbit antibody (Santa Cruz Biotechnology). HRP-conju-
gated polyclonal goat anti-b actin antibody to assess equal
loading was used from Santa Cruz Biotechnology. Bands were
detected using ECL Western Blotting Detection Reagent
(Amersham Biosciences).
Determination of lactate dehydrogenase (LDH), aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
blood urea nitrogen (BUN), and creatine phosphokinase
(CK) levels
Plasma concentrations of LDH, AST, ALT, BUN, and CK were
analyzed using a clinical chemistry analyzer system (VetTest8008,
IDEXX Laboratories).
Determination of cytokine and chemokine levels
Concentrations of IL-10, IL-6, and MIP-2, were determined
using commercially available ELISA kits (R&D Systems) according
to the manufacturer’s instructions. The lower detection limit for all
these cytokines was 10 pg/ml.
Statistical Analysis
Survival statistics were performed using Kaplan-Meier curve
and log rank test. Two-tailed t testing was used to compare
cytokine concentrations, CFUs, and other laboratory parame-
ters. Statistical significance was assigned to p values smaller than
0.05.
CB2 Receptors in Sepsis
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CB2 receptors contribute to sepsis-induced mortality and
bacterial invasion
To begin to study the role of CB2 receptors, we first investigated
the effect of CB2 deficiency in CLP-induced septic peritonitis by
monitoring the survival of CB2 WT and KO mice. As
demonstrated in Figure 1a, CB2 receptor KO mice had
significantly lower mortality rates compared with WT mice,
which became apparent on the 2nd day of observation. On the 7th
day following CLP, the mortality rate of CB2 KO mice was
markedly (by more than 40%) lower than that of CB2 WT mice.
No additional changes in mortality were detected when the mice
were monitored for up to 10 days (data not shown). Because
persistence of local bacterial infection and bloodstream invasion
play important roles in mortality in the CLP model, we next
assessed the impact of CB2 receptor inactivation on bacterial levels
at the primary peritoneal site of infection and in the blood stream.
We found markedly decreased numbers of bacteria in the blood
but not peritoneal lavage fluid of CB2 receptor KO mice when
compared to WT animals at 16 hours after CLP (Figure 1b, c).
Taken together, these studies document that CB2 receptors
contribute to bacterial translocation into the bloodstream and
mortality in polymicrobial sepsis.
CB2 receptor inactivation diminishes the production of
IL-10, IL-6 and MIP-2 in CLP-induced sepsis
Because IL-10 overproduction contributes to the impairment of
host antibacterial defenses seen in mice undergoing CLP [28–31],
wenextcomparedIL-10inthe plasmaandperitoneallavagefluidof
CB2 KO and WT mice subjected to CLP. CB2 KO mice exhibited
markedly lower levels of IL-10 at 16 h after CLP (Figure 2a, b).
Figure 1. CB2 deficiency decreases mortality and bacterial burden in polymicrobial sepsis elicited by CLP. (a) Surviving CB2 KO and WT
mice were counted every day for 7 days after inducing polymicrobial sepsis by way of cecal ligation and puncture (CLP). p,0.001 versus WT. (b)
Blood and (c) peritoneal lavage fluid obtained from CB2 KO or WT mice 16 hour after CLP were cultured on soy-trypticase agar plates, and the
number of bacterial colonies was counted. Data are the mean6SEM of n=6–9 mice per group. *p,0.05.
doi:10.1371/journal.pone.0006409.g001
CB2 Receptors in Sepsis
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6409Figure 2. CB2 receptor deficiency decreases IL-10, IL-6, and MIP-2 levels in the plasma and peritoneal lavage fluid of mice subjected
to CLP. IL-10 (a,b), IL-6 (c,d) and MIP-2 (e,f) concentrations were measured at 16 hours after surgery using ELISA. Data are the mean6SEM of n=6–9
mice per group. ***p,0.001; **p,0.01.
doi:10.1371/journal.pone.0006409.g002
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be protective in CLP-induced sepsis [32], we next assessed the role
of CB2 receptors in regulating IL-6 production during sepsis.
Plasma and peritoneal lavage fluid had lower levels of IL-6 in CLP-
induced CB2 KO mice than their WT littermates (Figure 2c,d).
We then determined the levels of macrophage-inflammatory
protein-2 (MIP-2), a crucial chemokine that mediates inflamma-
tory responses, in the plasma and peritoneal lavage fluid of CB2
KO and WT mice subjected to CLP, and we found that CLP-
induced concentrations of MIP-2 were diminished in CB2 KO
Figure 3. CB2 KO mice have less tissue damage, kidney and muscle injury in sepsis than their WT counterparts. LDH (a), AST (b), ALT
(c), and CK (d) activity, and BUN (e) levels were measured in plasma samples 16 hour after CLP using a clinical chemistry analyzer system
(VetTest8008, IDEXX Laboratories). Data are the mean6SEM of n=6–9 mice per group. **p,0.01; * p,0.05.
doi:10.1371/journal.pone.0006409.g003
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16 h after CLP (Figure 2e, f).
Mice deficient in CB2 receptor show decreased level of
markers of tissue damage, and kidney and muscle injury
We next measured markers of disease severity and organ
damage in an attempt to provide further explanation for the
improved survival of CB2 receptor KO mice. Levels of LDH
(Figure 3a), were lower in CB2 KO mice, indicating less tissue
damage in general. Markers of liver (AST and ALT) function were
not different between the WT and KO groups (Figure 3b, c). In
addition, we could not detect any lung inflammation in CLP-
challenged mice as assessed by histological analysis of lung
sections, and detecting myeloperoxidase activity in lung tissue
homogenates after 16 hour of CLP (data not shown). Finally, CK
activity and BUN levels were lower in CB2 KO mice indicating
preserved kidney function and lessened muscle (both heart and
skeletal) damage, respectively (Figure 3d,e).
CB2 receptor deficiency decreases NF-kB activation in
CLP-induced sepsis
Microbial components and endogenous danger signals trigger
the activation of signaling cascades leading to induction of the NF-
kB system during sepsis. Persistent activation of NF-kB may cause
excessive inflammatory responses culminating in tissue injury,
organ dysfunction, and death. We, therefore, studied the
activation of NF-kB by measuring levels of the IkBa in spleen of
septic animals. As Figure 4 shows, the levels of IkBa were
increased in the spleen of CB2 KO as compared to WT mice,
indicating decreased NF-kB activation in KO mice.
Genetic deletion of the CB2 receptor diminishes
apoptosis in lymphoid organs
Sepsis provokes extensive immune cell apoptosis that contrib-
utes to immune dysregulation and mortality. This was borne out
by studies demonstrating that transfer of apoptotic splenocytes
worsens survival in CLP-induced sepsis [33]. Because proteolytic
cleavage of caspase-3 and PARP is a good indicator of apoptosis,
we tested whether CB2 receptor deficiency would affect the
cleavage of caspase-3 and PARP in the spleen and thymus of mice
subjected to CLP. Figure 5 shows that 16 hours after the onset of
sepsis, the cleavage of both caspase-3 and PARP was markedly
decreased in thymus and spleen of CB2 receptor KO mice.
Lack of CB2 receptors augments the number of CD11b
+
and CD19
+ cells during CLP
CLP-challenged mice exhibit a decrease in white blood cell
numbers,which includes CD11b




KO mice have cell counts comparable to their WT counterparts
[36]. Flow-cytometric analysis of cell counts revealed that CLP-
challenged CB2 KO mice have increased numbers of total white
blood cells (Figure 6a), CD11b
+ (Figure 6b) cells and CD19
+ B
lymphocytes (Figure 6c) in comparison with CB2 WT mice, whereas
the number of CD3
+ T cells (Figure 6d) was comparable between
WT and KO mice undergoing CLP. We propose that preserved
Figure 4. CB2 receptor deficiency is associated with augmented
IkBa levels in CLP-induced sepsis. IkBa degradation was assessed
using Western blotting of spleen protein extracts of CB2 WT and KO
mice. Protein extracts were generated from spleen taken 16 hours after
sepsis induction. Bands were detected by enchanced chemilumines-
cence (ECL). Results (mean6SEM) shown are representative of 3
experiments. **p,0.01 versus WT.
doi:10.1371/journal.pone.0006409.g004
Figure 5. CB2 receptor deficiency decreases apoptosis in septic thymus and spleen. Proteolytic cleavage of caspase-3 and PARP in thymus
and spleen protein extracts from CB2 WT and KO mice was examined using Western blotting. Bands were detected by enchanced chemiluminescence
(ECL). Results shown are representative of 3 experiments.
doi:10.1371/journal.pone.0006409.g005
CB2 Receptors in Sepsis
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bacterial growth and mortality of these mice.
Discussion
Current concepts suggest that sepsis is the consequence of the
inability of the immune system to ward off infecting pathogens due
to immune system dysfunction. The mechanisms underlying these
immune functional abnormalities are largely unknown. Recent
studies have expanded the list of potential mediators to molecules
that are produced locally by infected and inflamed tissues and act
on specific G protein-coupled receptors expressed on immune cells
to inhibit their function. These molecules include adenosine
[37,38], which bind to and trigger their receptors on lymphocytes,
macrophages, and neutrophils, thereby diminishing anti-bacterial
defenses. In these studies we have focused on a new type of
immunosuppressive G protein-coupled receptor, the CB2 canna-
binoid receptor, which is expressed primarily by immune cells and
is activated by locally released endocannabinoids. Using the CLP
model of sepsis, we found that CB2 receptor activation by
endogenously released cannabinoids contributes to mortality,
bacterial invasion, IL-10 production, and immune cell death in
sepsis.
Studies utilizing antibiotic therapy have shown that systemic
bacterial dissemination is a major factor contributing to the
mortality of both experimental animals and humans during sepsis
[39–41]. Our studies showed that bacterial burden was decreased
in CB2 receptor KO mice suggesting that CB2 receptor activation
contributes mortality by increasing systemic bacterial burden
during sepsis. One potential explanation for the decreased
bacterial load in mice lacking CB2 receptors is a decrease in the
levels of the immunosuppressive IL-10 leading to a better
preserved phagocytic response. IL-10 is an immunoregulatory
cytokine that is released primarily by macrophages during sepsis.
IL-10 is an important contributor to the dysregulated immune
system that is observed in sepsis [28–31,42]. Recent studies have
shown that CB2 receptor activation can upregulate IL-10
production across a number of experimental systems that utilize
macrophages [22,43]. Given the relevance of IL-10 in sepsis, the
effect of CB2 receptor activation on IL-10 release is likely to be a
major determinant of the immunomodulatory action of CB2
receptor activation in sepsis.
Sepsis instigates widespread immune cell apoptosis, and
mortality in this illness is thought to be, at least in part, a
consequence of dysregulated immune cell death [44–46]. CB2
receptor triggering induces both T and B lymphocyte apoptosis in
Figure 6. Effect of CB2 receptor inactivation on the leukocyte cell subsets in the blood during CLP. Numbers of total white cell (a),a s
well as CD11b
+ (b), CD19
+ (c), and CD3
+ (d) cells were monitored in blood by flow cytometric analysis after 16 hours of sepsis induced by CLP. Data
are the mean6SEM of n=6–9 mice per group. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0006409.g006
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cleavage as well as PARP cleavage in CB2 KO mice following
sepsis indicate that CB2 receptors are essential contributors to
apoptotic processes also in vivo. Moreover, we found increased
numbers of CD11b
+ and CD19
+cells in blood of CB2 KO mice
suggesting that CB2 receptors contribute to bacterial invasion by
CD11b
+ and B cell depletion in the bloodstream. The immuno-
suppressive role of CB2 receptors has been confirmed recently in
vivo by inducing immune-mediated inflammatory disease in CB2
receptor KO and WT mice. CB2 receptor KO mice develop a
more severe form of experimental allergic encephalomyelitis in
comparison with WT mice, which is a consequence of increased
T-cell activation and decreased T-cell apoptosis in KO vs. WT
mice [53]. In another model, CB2 receptor KO mice displayed
increased allergic responses in the skin, which was secondary to
increased production of proinflammatory cytokines [54]. More-
over, we have recently demonstrated that CB2 receptor KO mice
exhibit exacerbated liver injury following hepatic ischemia/
reperfusion, which is associated with increased production of
pro-inflammatory cytokines and neutrophil infiltration into the
liver [14]. Our results that CB2 receptor inactivation decreases
mortality during CLP-induced bacterial (non-sterile) sepsis might
seem contradictory to the observations in experimental allergic
encephalomyelitis, allergic skin inflammation, and ischemia/
reperfusion-induced inflammation in that CB2 receptor inactiva-
tion is injurious in these sterile inflammation models. But we
believe the data seen as a whole suggests that differences in
outcome in the two types of model are due to immunosuppression
being beneficial in sterile inflammation/ischemia but detrimental
in clinically relevant models of infection-induced sepsis where
mortality depends more upon the inability to mount an immune
response leading to a loss of control of bacterial growth.
In summary, we found that CB2 receptor activation by
endogenously released cannabinoids contributes to mortality,
bacterial invasion, IL-10 production, and immune cell death in
sepsis. Based on these observations, we suggest that CB2 receptor
triggering contributes to the development of immune system
dysfunction that leads to mortality in sepsis.
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